Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits.

Area of Science:

• Neuroscience
• Molecular Biology
• Synaptic Plasticity

Background:

• Amyloid beta 42 (Aβ42) aggregates acutely impair hippocampal long-term potentiation (LTP), a key mechanism for memory formation.
• Neural-derived 17β-estradiol (nE2) is essential for hippocampal LTP.

Purpose of the Study:

• To investigate if boosting nE2 synthesis can protect hippocampal LTP against Aβ42-induced neurotoxicity.
• To explore the mechanism underlying nE2's neuroprotective effects.

Main Methods:

• Electrophysiological recordings in rat hippocampal slices to measure dentate gyrus (DG) LTP.
• Pharmacological manipulation using finasteride to increase nE2 synthesis and memantine to modulate NMDAR activity.

Main Results:

• Increased nE2 synthesis via finasteride completely restored LTP impaired by Aβ42 aggregates.
• Memantine, a NMDAR modulator, rescued Aβ42-induced LTP deficits and prevented LTP reduction when nE2 synthesis was blocked.
• nE2 counteracted Aβ42-induced synaptic dysfunction through a rapid, non-genomic mechanism potentially involving NMDAR signaling.

Conclusions:

• Boosting endogenous nE2 synthesis is a viable strategy to counteract Aβ42-induced synaptic dysfunction.
• The protective effects of nE2 against Aβ42 involve rapid, non-genomic actions that may converge with NMDAR signaling pathways.